World Journal of Laparoscopic Surgery

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2017 ) > List of Articles


Short- and Long-term Effects of Laparoscopic Sleeve Gastrectomy on Body Weight and Glucose Homeostasis in Diabetic Patients

Hazem Badr, Mohamed Abdelmohsen

Citation Information : Badr H, Abdelmohsen M. Short- and Long-term Effects of Laparoscopic Sleeve Gastrectomy on Body Weight and Glucose Homeostasis in Diabetic Patients. World J Lap Surg 2017; 10 (2):45-50.

DOI: 10.5005/jp-journals-10033-1301

License: CC BY-NC 4.0

Published Online: 01-09-2011

Copyright Statement:  Copyright © 2017; The Author(s).



Laparoscopic sleeve gastrectomy (LSG) is being performed more frequently and is currently very “trendy” among laparoscopic surgeons involved in bariatric surgery. Laparoscopic sleeve gastrectomy is associated with a marked reduction of ghrelin secretion, which is produced by the gastric fundus involved in mealtime hunger regulation, and it is also known to extend several diabetogenic effects.


The aim of this study is to assess the short- and long-term effects of LSG on body weight and glucose homeostasis in morbidly obese diabetic patients.

Materials and methods

This is a prospective study that was conducted on 40 diabetic patients randomly selected suffering from morbid obesity that had type II diabetes mellitus (T2DM). Patients were managed by LSG in AL-Zahraa Hospital, Faculty of Medicine for girls, Al-Azhar University, from January 2012 to December 2015, to assess the short- and long-term effects of the procedure on glucose homeostasis.


The study was conducted on 40 patients of morbid obesity that had T2DM. The preoperative mean fasting blood glucose (FBG) level was 209.3 ± 36.6 (156–299) mg/dL and postoperatively was 172.5 ± 29 (130–250) mg/dL, 125.6 ± 16.7 (99–169) mg/dL, 111.7 ± 20.9 (77–167) mg/dL, 105 ± 18.3 (73–137) mg/dL, and 102.9 ± 21 (70–145) mg/dL at 1 day and 3, 6, 9, and 12 months respectively. Postoperatively, the FBG levels were improved with significant declining at 1 day (p < 0.001), 3 months (p < 0.001), and 6 months (p < 0.004) but nonsignificant declining at 9 months (p < 0.25) and 12 months (p = 1).


Laparoscopic sleeve gastrectomy is an effective surgical treatment for most severely or morbidly obese patients with DM. Weight loss is effective treatment for patients with these medical problems. The SG is associated with a high rate of resolution of T2DM at 12 months after surgery in severely obese patients with T2DM.

How to cite this article

Abdelmohsen M, Badr H. Short- and Long-term Effects of Laparoscopic Sleeve Gastrectomy on Body Weight and Glucose Homeostasis in Diabetic Patients. World J Lap Surg 2017;10(2):45-50.

  1. Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group. Acta Cardiol 2007 Apr;62(2):119-127.
  2. Effect of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Relat Dis 2009 Jul-Aug;5(4):429-434.
  3. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987 Jun;205(6):613-624.
  4. Consistency and change of body mass index and weight. A study on 5967 adult Finnish twin pairs. Int J Obes Relat Metab Disord 1995 May;19(5):310-317.
  5. Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited. Obes Surg 1995 Nov;5(4):411-418.
  6. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000 Dec;10(6):514-523.
  7. Surgical treatment of morbid obesity. Sixteen years of experience. Arch Surg 1973 Apr;106(4):432-437.
  8. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg 2003 Oct;13(5):699-705.
  9. Surgery for severe obesity. N Engl J Med 2004 Mar;350(11):1075-1079.
  10. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003 Oct;238(4):467-484.
  11. Achievement of near-normal body weight as the prerequisite to normalize sex hormone-binding globulin concentrations in massively obese men. Int J Obes Relat Metab Disord 1997 Jan;21(1):1-5.
  12. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008 Jan;299(3):316-323.
  13. Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus. ANZ J Surg 2007 Nov;77(11):958-962.
  14. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008 Sep;18(9):1077-1082.
  15. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009 Aug;250(2):234-241.
  16. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterol Clin North Am 2010 Mar;39(1):109-124.
  17. Impact of sleeve gastrectomy on weight loss, Glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes 2011;2011:340867.
  18. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 2010 Jan;20(1):50-55.
  19. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010 Apr;110(4):571-584.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.